Epizootic shell disease (ESD) affects lobsters (Homarus americanus) in eastern Long Island Sound (ELIS) and the near-shore waters of southern New England. Marring the shell of individuals, ESD decreases the economic value of infected lobsters and can lead to mortality in severely affected individuals. ESD tends to be most common in areas around Buzzards Bay, RI, and ELIS, and least prevalent in offshore canyons, off Maine's coast, and in western Long Island Sound (WLIS). To investigate the potential role of the immune system in determining an individual's or population's susceptibility to ESD, the immunocompetence and disease status of lobsters with and without signs of ESD from ELIS, WLIS, and Boothbay Harbor, ME, were assessed during late spring (June) 2007. We also measured internal defense parameters of ELIS lobsters during midsummer (August 2007), early fall (October 2007), and the following spring (June 2008) to assess how lobster immune systems respond temporarily. Despite high interindividual variability in defense-related factors, multivariate analyses showed that lobsters from ELIS presented significantly reduced immune responses relative to lobsters from either WLIS or Maine. Disease severity correlated negatively with several immune parameters, suggesting that the higher prevalence of ESD in ELIS may be related, at least in part, to reduced immunocompetency of ELIS lobsters.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 31 • No. 2